Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideki Kuga is active.

Publication


Featured researches published by Hideki Kuga.


Clinical & Experimental Allergy | 2006

Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-κB and/or IRF-3 in airway epithelial cells

Satoshi Matsukura; Fumio Kokubu; Masatsugu Kurokawa; Mio Kawaguchi; Koushi Ieki; Hideki Kuga; Miho Odaka; S. Suzuki; Hiroko Takeuchi; Tsuyoshi Kasama; Mitsuru Adachi

Background We hypothesized that synthetic double‐stranded (ds)RNA may mimic viral infection and induce expression of genes related to inflammation in airway epithelial cells.


International Archives of Allergy and Immunology | 2007

Role of RIG-I, MDA-5, and PKR on the Expression of Inflammatory Chemokines Induced by Synthetic dsRNA in Airway Epithelial Cells

Satoshi Matsukura; Fumio Kokubu; Masatsugu Kurokawa; Mio Kawaguchi; Koushi Ieki; Hideki Kuga; Miho Odaka; Shintaro Suzuki; Shin Watanabe; Tetsuya Homma; Hiroko Takeuchi; Kyoko Nohtomi; Mitsuru Adachi

Background: We hypothesized that synthetic double-stranded (ds)RNA may mimic viral infection and reported that dsRNA stimulates expression of inflammatory chemokines through a receptor of dsRNA Toll-like receptor (TLR) 3 in airway epithelial cells. In this study, we focused our study on the role of other receptors for dsRNA, such as retinoic acid-inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA-5), and double-stranded RNA-dependent protein kinase (PKR). Methods: Airway epithelial cell BEAS-2B was cultured in vitro. Expression of target RNA and protein were analyzed by PCR and ELISA. To analyze the role of receptors for dsRNA, knockdown of theses genes was performed with short interfering RNA (siRNA). Results: We first investigated the effects of chloroquine, an inhibitor of lysosomal acidification, on the expression of chemokines. Preincubation with 100 µM chloroquine significantly inhibited the expression of mRNA for RANTES, IP-10, and IL-8, stimulated by poly I:C, indicating that poly I:C may react with a receptor expressed inside the cells. RIG-I, MDA-5, and PKR are supposed to be expressed inside the airway epithelial cells. However, the expression of chemokines stimulated with poly I:C was not significantly inhibited for these putative receptors in the cells which were transfected with siRNA. Conclusions: Synthetic dsRNA poly I:C stimulates the expression of inflammatory chemokines in airway epithelial cells, but the putative receptors for dsRNA such as RIG-I, MDA-5, or PKR may not play pivotal roles in this process. TLR3 may play a major role as reported previously.


Clinical & Experimental Allergy | 2004

Double‐stranded RNA activates RANTES gene transcription through co‐operation of nuclear factor‐κB and interferon regulatory factors in human airway epithelial cells

Koushi Ieki; Satoshi Matsukura; Fumio Kokubu; Teruaki Kimura; Hideki Kuga; Mio Kawaguchi; Miho Odaka; S. Suzuki; Shin Watanabe; Hiroko Takeuchi; Robert P. Schleimer; Mitsuru Adachi

Background Regulated on activation, normal T cells expressed and secreted (RANTES) is a member of the CC chemokine family and contributes to viral‐induced airway inflammation including exacerbations of asthma. Double‐stranded RNA (dsRNA) is known to be synthesized during replication of many viruses and a ligand of Toll‐like receptor 3. We hypothesized that dsRNA may mimic viral infection and induce RANTES expression in airway epithelial cells.


International Archives of Allergy and Immunology | 2000

Expression of Eotaxin by Normal Airway Epithelial Cells after Influenza Virus A Infection

Mio Kawaguchi; Fumio Kokubu; Hideki Kuga; Takeshi Tomita; Satoshi Matsukura; Mitsutaka Kadokura; Mitsuru Adachi

Background: Viral infection is known to cause lung inflammatory disease, including bronchial asthma. The mechanisms of inflammatory cell accumulation into the airways after viral infection are not well understood. Eotaxin is a CC chemokine which is a potent and specific agonist for CC chemokine receptor 3 (CCR3). CCR3 is expressed on eosinophils, basophils and T lymphocytes. These cells are known to be key cells in the pathogenesis of asthma. Although it has recently been demonstrated that airway epithelial cells express eotaxin in vivo and in vitro, there are few data about its epxression in viral infection. We hypothesized that eotaxin may play an important role in attracting inflammatory cells to the airways after viral infection, and analyzed whether viral infection attracts eotaxin in bronchial epithelial cells in vitro. Methods: Human airway epithelial cells obtained from bronchial tissue at lobectomy for lung cancer were infected with influenza virus A (subtype H3N2). The cells and cultured media were collected 8, 24, and 48 h after infection. Eotaxin mRNA was analyzed with reverse transcriptase-polymerase chain reaction. Eotaxin protein levels in the culture media were analyzed by enzyme-linked immunosorbent assay. We also studied a blocking assay to analyze the intervention of proinflammatory cytokines in its production induced by influenza virus. Results: Eotaxin mRNA appeared to be expressed constitutively in uninfected cells but was expressed more clearly in infected cells. Eotaxin protein release into culture media significantly increased after infection. Anti-TNF-α and anti-IL-1β antibodies did not alter the eotaxin protein levels after viral infection. Conclusions: These results suggest that influenza virus A infection in airway epithelial cells activates the expression of eotaxin and that eotaxin may participate in the pathogenesis of airway inflammatory disease caused by viral infection, such as infectious type asthma.


International Archives of Allergy and Immunology | 2007

Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smooth muscle cells.

Miho Odaka; Satoshi Matsukura; Hideki Kuga; Fumio Kokubu; Tsuyoshi Kasama; Masatsugu Kurokawa; Mio Kawaguchi; Koushi Ieki; Shintaro Suzuki; Shin Watanabe; Tetsuya Homma; Hiroko Takeuchi; Kyoko Nohtomi; Robert P. Schleimer; Mitsuru Adachi

Background: Airway smooth muscle (ASM) cells may contribute to the pathogenesis of asthma including airway inflammation and remodeling. We focused our study on the regulation of chemokine expression by cytokines and analyzed the mechanisms of eotaxin/CCL-11 expression in ASM cells. Methods: Human ASM cells were cultured in vitroand treated with IL-4, interferon-γ (IFNγ), and tumor necrosis factor-α (TNFα). Secretion of chemokines into the culture medium was analyzed by ELISA. Expression of eotaxin mRNA was analyzed by reverse transcription-polymerase chain reaction (RT-PCR). Binding of transcription factor signal transducer activator of transcription (STAT) 6 to the eotaxin promoter-derived DNA was analyzed by pull-down Western blot. To assess transcriptional regulation of eotaxin, cells were transfected with eotaxin promoter-luciferase reporter plasmids, and activity was determined by dual luciferase assay. Results: The Th2 cytokine IL-4 preferentially stimulated the expression of the CC chemokine receptor (CCR) 3-ligand chemokines eotaxin, eotaxin-3, and MCP-4. The Th1 cytokine IFNγ stimulated the expression of chemokines IP-10 and RANTES. IL-4 stimulated nuclear translocation of signal transducer activator of transcription 6 (STAT6) and its binding to the eotaxin promoter region. IL-4 activated the eotaxin promoter and its activity was inhibited by mutation of the binding site for STAT6 in the promoter. Conclusions: The Th2 cytokine IL-4 preferentially stimulated the expression of CCR3 ligand chemokines including eotaxin in ASM cells. The transcription factor STAT6 may play a pivotal role in the activation of eotaxin transcription in response to IL-4.


International Archives of Allergy and Immunology | 2004

Molecular Mechanisms of Repression of Eotaxin Expression with Fluticasone Propionate in Airway Epithelial Cells

Satoshi Matsukura; Fumio Kokubu; Masatsugu Kurokawa; Mio Kawaguchi; Hideki Kuga; Koushi Ieki; Miho Odaka; Shintaro Suzuki; Shin Watanabe; Hiroko Takeuchi; Robert P. Schleimer; Ulrike Schindler; Mitsuru Adachi

Background: Glucocorticoids are known to repress the expression of CC chemokine eotaxin in airway epithelial cells. We focused our study on the molecular mechanisms of the glucocorticoid, fluticasone, in the inhibition of the expression of the eotaxin gene in the cells. Methods: The airway epithelial cell line, BEAS-2B, was stably transfected with signal transducers and activators of transcription 6 (STAT6)-expressing vector and used in the following experiments to clarify the function of STAT6. Levels of eotaxin mRNA and protein expression were determined with RT-PCR and ELISA. Mechanisms of transcriptional regulation were assessed by the electrophoretic mobility shift assay and dual luciferase assay using eotaxin promoter-luciferase reporter plasmids. Results: Fluticasone significantly inhibited the induction of eotaxin protein stimulated with TNF-α and IL-4 in the cells. Fluticasone also repressed the induction of eotaxin mRNA with these stimuli. It partially inhibited the activity of eotaxin promoter; however, it did not inhibit the nuclear translocation and binding of transcription factors, nuclear factor-kappa B (NF-ĸB) or STAT6, to the DNA derived from the proximal promoter region of the eotaxin gene. Moreover, the inhibitory effect was also conserved in the experiments using the reporter plasmid of which the putative glucocorticoid-responsive element was mutated. Conclusions: Fluticasone inhibits the expression of eotaxin gene in airway epithelial cells in part through repression of the transcription. However, the mechanisms depend neither on the inhibition of transcription factors’ translocation into nuclei nor the function of the putative glucocorticoid-responsive element in the promoter, indicating that other mechanisms would be related to the transcriptional repression of the eotaxin gene in airway epithelial cells.


Clinical & Experimental Allergy | 2010

Transforming growth factor‐β stimulates the expression of eotaxin/CC chemokine ligand 11 and its promoter activity through binding site for nuclear factor‐κB in airway smooth muscle cells

Satoshi Matsukura; Miho Odaka; Masatsugu Kurokawa; Hideki Kuga; Tetsuya Homma; Hiroko Takeuchi; Kyoko Notomi; Fumio Kokubu; Mio Kawaguchi; Robert P. Schleimer; M. W. Johnson; Mitsuru Adachi

Background Chemokines ligands of CCR3 including eotaxin/CC chemokine ligand 11 (CCL11) may contribute to the pathogenesis of asthma. These chemokines and a growth factor (TGF‐β) may be involved in the process of airway remodelling.


Clinical & Experimental Allergy | 2001

Influenza virus A stimulates expression of eotaxin by nasal epithelial cells

Mio Kawaguchi; Fumio Kokubu; Hideki Kuga; T. Tomita; Satoshi Matsukura; Harumi Suzaki; Shau-Ku Huang; Mitsuru Adachi

Background Respiratory virus is one of the most common causes of airway inflammation, but its pathogenic mechanisms are not well understood. Eotaxin is a potent eosinophil chemoattractant and is a selective agonist for C‐C chemokine receptor 3 (CCR3). Although it has recently been demonstrated that epithelial cells express eotaxin, both in vivo and in vitro, there are few data concerning the expression in viral infection.


The Journal of Allergy and Clinical Immunology | 2003

Differential regulation of eotaxin expression by IFN-γ in airway epithelial cells

Satoshi Matsukura; Fumio Kokubu; Hideki Kuga; Mio Kawaguchi; Koushi Ieki; Miho Odaka; S. Suzuki; Shin Watanabe; Hiroko Takeuchi; Mitsuru Adachi; Cristiana Stellato; Robert P. Schleimer


Arerugī (Allergy) | 1999

[Effect of IL-17 on ICAM-1 expression of human bronchial epithelial cells, NCI-H 292].

Mio Kawaguchi; Fumio Kokubu; Hideki Kuga; Tomita T; Satoshi Matsukura; Hoshino H; Imai T; Mitsuru Adachi

Collaboration


Dive into the Hideki Kuga's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mitsuru Adachi

International University of Health and Welfare

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge